Understanding GABAA receptor protein folding and misfolding

了解 GABAA 受体蛋白折叠和错误折叠

基本信息

  • 批准号:
    10383160
  • 负责人:
  • 金额:
    $ 35.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Project Description Proteostasis, an optimal state of the cellular proteome, is constantly challenged by intrinsic stress, such as inherited misfolding-prone proteins, environment, and aging. Proteostasis deficiency in ion channels leads to a variety of ion channel diseases called channelopathies, which are often caused by excessive endoplasmic reticulum-associated degradation (ERAD) and inefficient membrane trafficking of corresponding ion channel proteins harboring misfolding-prone mutations. We use gamma- aminobutyric acid type A (GABAA) receptors, the primary inhibitory neurotransmitter-gated ion channels in the mammalian central nervous systems, as a representative ion channel, to elucidate their folding and ERAD pathway in the endoplasmic reticulum (ER). The interaction between GABAA receptors and a network of proteins in cells is critical to maintain the folding, degradation, trafficking, and thus function of GABAA receptors. However, the molecular mechanism of maintaining GABAA receptor proteostasis is not well understood. Idiopathic epilepsy has a strong genetic linkage to loss of function of GABAA receptors. We focus on studying missense mutations that lead to misfolding, extensive degradation, and thus loss of function of mutant GABAA receptors. Our long term goal is to perform a detailed molecular mechanism study to elucidate how the folding, assembly, degradation of GABAA receptors are regulated in cells and use the principles acquired to correct epilepsy-associated misfolded GABAA receptors. Here, in Specific Aim 1, we aim to elucidate a coordinated engagement of chaperones and folding enzymes in directing the folding of GABAA receptors in the ER. In Specific Aim 2, we aim to determine the ERAD pathway of misfolding-prone mutant GABAA receptors. In Specific Aim 3, we propose to remodel the ER proteostasis network to correct the misfolding and function of pathogenic GABAA receptors. This proposed research will provide proof-of-principle cases about restoring proteostasis to ameliorate genetic epilepsy resulting from GABAA receptor misfolding.
项目描述

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tingwei Mu其他文献

Tingwei Mu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tingwei Mu', 18)}}的其他基金

Understanding GABAA receptor protein folding and misfolding
了解 GABAA 受体蛋白折叠和错误折叠
  • 批准号:
    10744869
  • 财政年份:
    2023
  • 资助金额:
    $ 35.18万
  • 项目类别:
Assembly Chaperone Complex for Membrane Proteins in the Endoplasmic Reticulum
内质网膜蛋白的组装伴侣复合物
  • 批准号:
    10569014
  • 财政年份:
    2020
  • 资助金额:
    $ 35.18万
  • 项目类别:
Assembly Chaperone Complex for Membrane Proteins in the Endoplasmic Reticulum
内质网膜蛋白的组装伴侣复合物
  • 批准号:
    10302235
  • 财政年份:
    2020
  • 资助金额:
    $ 35.18万
  • 项目类别:
Assembly Chaperone Complex for Membrane Proteins in the Endoplasmic Reticulum
内质网膜蛋白的组装伴侣复合物
  • 批准号:
    10359803
  • 财政年份:
    2020
  • 资助金额:
    $ 35.18万
  • 项目类别:
Understanding GABAA receptor protein folding and misfolding
了解 GABAA 受体蛋白折叠和错误折叠
  • 批准号:
    9919648
  • 财政年份:
    2018
  • 资助金额:
    $ 35.18万
  • 项目类别:

相似海外基金

Replication Stress and Ribosome Biogenesis in Hematopoietic Stem Cell Aging
造血干细胞衰老中的复制应激和核糖体生物合成
  • 批准号:
    10529275
  • 财政年份:
    2021
  • 资助金额:
    $ 35.18万
  • 项目类别:
Replication Stress and Ribosome Biogenesis in Hematopoietic Stem Cell Aging
造血干细胞衰老中的复制应激和核糖体生物合成
  • 批准号:
    10684178
  • 财政年份:
    2021
  • 资助金额:
    $ 35.18万
  • 项目类别:
Replication Stress and Ribosome Biogenesis in Hematopoietic Stem Cell Aging
造血干细胞衰老中的复制应激和核糖体生物合成
  • 批准号:
    10314933
  • 财政年份:
    2021
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    10188372
  • 财政年份:
    2018
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    10447765
  • 财政年份:
    2018
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    9767003
  • 财政年份:
    2018
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitophagy and lysosomal biogenesis in aging muscle
衰老肌肉中的线粒体自噬和溶酶体生物发生
  • 批准号:
    371850
  • 财政年份:
    2017
  • 资助金额:
    $ 35.18万
  • 项目类别:
    Operating Grants
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    9940855
  • 财政年份:
    2017
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    10443536
  • 财政年份:
    2017
  • 资助金额:
    $ 35.18万
  • 项目类别:
Mitochondrial biogenesis, genetics and cell loss in mammalian aging
哺乳动物衰老过程中的线粒体生物发生、遗传学和细胞损失
  • 批准号:
    9285634
  • 财政年份:
    2017
  • 资助金额:
    $ 35.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了